Transaction DateRecipientSharesTypePriceValue
20th November 2020Scott D Sandell97Open or private sale$65.64$6,367.08
20th November 2020Scott D Sandell69,564Open or private sale$67.27$4,679,507.67
19th November 2020Scott D Sandell267,743Open or private sale$65.84$17,626,913.95
18th November 2020Scott D Sandell51,428Open or private sale$65.53$3,369,871.13
17th November 2020Scott D Sandell312,171Open or private sale$65.62$20,484,879.54
16th November 2020Scott D Sandell86,980Open or private sale$64.24$5,587,751.76
13th November 2020Scott D Sandell20,578Other acquisition or disposition$0.00
13th November 2020Scott D Sandell165,945Other acquisition or disposition$0.00
13th November 2020Scott D Sandell767,500Other acquisition or disposition$0.00
13th November 2020Scott D Sandell767,500Other acquisition or disposition$0.00
Inozyme Pharma
Inozyme Pharma logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.



Ticker: INZY
Sector: Unknown
Industry: Unknown
SEC Central Index Key (CIK): 1693011
Employees:
Exchange:
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals